Skip to content
Austin Top 50
Author:
Immuneering Corporation
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
April 20, 2026
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
April 6, 2026
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
March 17, 2026
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 6, 2026
←
Previous Page
1
2